NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease
Journal for ImmunoTherapy of Cancer · 2024
DOI: 10.1136/jitc-2024-009198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2024. Verfasst von Carla Panisello und 15 weiteren Autor:innen. Beteiligte Einrichtung: Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain. Hauptthemen laut MEDLINE: Graft vs Host Disease, Mice, Inbred NOD, Fetal Blood, Leukocytes, Mononuclear. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agencia Estatal de Investigación, Centres de Recerca de Catalunya, Fundación Merck.
Abstract (Originalsprache)
Humanized immunodeficient mice serve as critical models for investigating the functional interplay between transplanted human cells and a pre-reconstituted human immune system. These models facilitate the study of molecular and cellular pathogenic mechanisms and enable the evaluation of the efficacy and toxicity of immunotherapies, thereby accelerating their preclinical and clinical development. Current strategies rely on inefficient, long-term/delayed hematopoietic reconstitution by CD34+ hematopoietic progenitors or short-term reconstitution with peripheral blood mononuclear cells (PB-MNCs) associated with high rates of graft-versus-host disease (GvHD) and an inefficient representation of immune cell populations. Here, we hypothesized that immunologically naïve cord blood mononuclear cells (CB-MNCs) could serve as a superior alternative, providing long-lasting and functionally effective immune reconstitution. We conducted a comprehensive comparison between the non-obese diabetic (NOD).Cg-Prkdc∧ˆscid-IL2rg∧ˆtm1Wjl/SzJ (NSG) and NSG-Tg(CMV-IL3,CSF2,KITLG)∧ˆ1Eav/MloySzJ (NSGS) immunodeficient mouse models following humanization with either PB-MNCs or CB-MNCs. We assessed the engraftment dynamics of various human immune cells over time and monitored the development of GvHD in both models. For the most promising model, we extensively evaluated immune cell functionality in vitro and in vivo using sarcoma and leukemia xenografts. Humanizing NSGS mice with CB-MNCs results in a rapid, robust, and sustained representation of a diverse range of functional human lymphoid and myeloid cell populations while minimizing GvHD incidence. In this model, human immune cell populations significantly impair the growth and engraftment of sarcoma and B-cell acute lymphoblastic leukemia cells, with a significant inverse correlation between immune cell levels and tumor growth. This study establishes a fast, efficient, and reliable in vivo platform for various applications in cancer immunotherapy, particularly for exploring the complex interactions between cancer cells, immune cells, and the tumor microenvironment in vivo , prior to clinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.
- Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
- Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
- PhD programme in Biomedicine, University of Barcelona, Barcelona, Spain.
- Paediatric Cancer Treatment, Sant Joan de Deu Research Institute, Barcelona, Spain.
- Department of Immunology and Immunotherapy, Hospital Clínic Barcelona, Barcelona, Spain.
ORCID-Profile: Carla Panisello, Manel Juan
Förderung
- Agencia Estatal de Investigación
- Centres de Recerca de Catalunya
- Fundación Merck
- 'la Caixa' Foundation
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- Fundación Josep Carreras Contra la Leucemia
- Instituto de Salud Carlos III
- EIT Health
Zitieren
APA
Panisello, C., Aschero, R., Martinez-Moreno, A., Roca Ho, H., Falgas, A., González-Navarro, E. A., Carabelli, J., Pradenas, E., Lázaro-Díez, M., Prado, J. G., Blanco, J., Carrillo, J., Juan, M., Carcaboso, Á. M., Bueno, C., & Menendez, P. (2024). NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-009198
Vancouver
Panisello C, Aschero R, Martinez-Moreno A, Roca Ho H, Falgas A, González-Navarro EA, et al. NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease. Journal for ImmunoTherapy of Cancer. 2024. doi:10.1136/jitc-2024-009198
BibTeX
@article{Panisello2024,
author = {Panisello, Carla and Aschero, Rosario and Martinez-Moreno, Alba and Roca Ho, Heleia and Falgas, Aida and González-Navarro, Europa Azucena and Carabelli, Julieta and Pradenas, Edwards and Lázaro-Díez, María and Prado, Julia G and Blanco, Julià and Carrillo, Jorge and Juan, Manel and Carcaboso, Ángel M and Bueno, Clara and Menendez, Pablo},
title = {NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2024},
doi = {10.1136/jitc-2024-009198}
}
EUVIMED